Synthasome, Inc – FDA 483, Jul 17, 2023

Synthasome, Inc. in Del Mar, CA, was inspected by the FDA from July 17-18, 2023, revealing deficiencies in their quality system. The inspection found that procedures for design transfer were not adequately established or documented. This indicates a need for improved procedural definition and record-keeping, particularly concerning transfers to contract manufacturers.